← Latest Filings
S

Sands Capital Life Sciences Pulse Fund II, L.P.

Open-market buys
1
$3.0M total
Open-market sells
0
$0 total
Tracking since
Nov 2025
Open-market buy — $3.0M
Open-market trades from the last two years.
13,018,965 Common Stock in IKT
Held directly · as of 2025-11-21
Inhibikase Therapeutics, Inc.
CIK 0001750149